Pass-Through Costs. Where PPD incurs Pass Through Costs in a currency other than the Contract Currency, PPD shall, for Sponsor invoicing and payment purposes, convert such costs to the Contract Currency based on an average exchange rate between the local currency and the Contract Currency for the month in which such costs were incurred.
Appears in 7 contracts
Samples: Master Development Services Agreement, Master Development Services Agreement, Master Development Services Agreement (Furiex Pharmaceuticals, Inc.)
Pass-Through Costs. Where PPD incurs Pass Through Costs in a currency other than the Contract Currency, PPD shall, for Sponsor invoicing and payment purposes, convert such costs to the Contract Currency based on an average exchange rate between the local currency and the Contract Currency for the month in which such costs were incurred. This average exchange rate will be based on the monthly average of the daily exchange rates as published in the Wall Street Journal.
Appears in 3 contracts
Samples: Master Services Agreement, Master Services Agreement (Galectin Therapeutics Inc), Master Services Agreement (Vascular Biogenics Ltd.)
Pass-Through Costs. Where PPD incurs Pass Through Costs in a currency other than the Contract Currency, PPD shall, for Sponsor invoicing and payment purposes, convert such costs to the Contract Currency based on an the average of the daily exchange rate rates as published in the Wall Street Journal between the local currency and the Contract Currency for the month in which such costs were incurred.
Appears in 1 contract
Samples: Master Services Agreement (Aastrom Biosciences Inc)
Pass-Through Costs. Where PPD incurs Pass Through Costs in a currency other than the Contract Currency, PPD shall, for Sponsor invoicing and payment purposes, convert such costs to the Contract Currency based on an average reasonable market exchange rate between the local currency and the Contract Currency for the month in which such costs were incurred.
Appears in 1 contract
Samples: Master Services Agreement (Celldex Therapeutics, Inc.)